These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 29626596)
1. Renal histology in a patient with TAFRO syndrome: a case report. Mizuno H; Sekine A; Oguro M; Oshima Y; Kawada M; Sumida K; Yamanouchi M; Hayami N; Suwabe T; Hiramatsu R; Hasegawa E; Hoshino J; Sawa N; Fujii T; Takaichi K; Ohashi K; Ubara Y Hum Pathol; 2018 Dec; 82():258-263. PubMed ID: 29626596 [TBL] [Abstract][Full Text] [Related]
2. Unexplained cause of thrombocytopenia, fever, anasarca and hypothyroidism: TAFRO syndrome with thrombotic microangiopathy renal histology. Simeni Njonnou SR; Deuson J; Royer-Chardon C; Vandergheynst FA; Wilde V BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32606113 [TBL] [Abstract][Full Text] [Related]
3. TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review. Nagayama Y; Yamano M; Yagame M; Nariyama T; Takahashi M; Kawamoto M; Matsui K BMC Nephrol; 2019 Oct; 20(1):375. PubMed ID: 31623576 [TBL] [Abstract][Full Text] [Related]
4. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature. Zhou Q; Zhang Y; Zhou G; Zhu J BMC Nephrol; 2020 Nov; 21(1):499. PubMed ID: 33225930 [TBL] [Abstract][Full Text] [Related]
5. The first case of thrombocytopenia, anasarca, fever, renal impairment or reticulin fibrosis, and organomegaly (TAFRO) syndrome with unilateral adrenal necrosis: a case report. Fujiwara Y; Ito K; Takamura A; Nagata K J Med Case Rep; 2018 Oct; 12(1):295. PubMed ID: 30293532 [TBL] [Abstract][Full Text] [Related]
6. Pathological findings of progressive renal involvement in a patient with TAFRO syndrome. Saito H; Tanaka K; Fujiwara M; Iwasaki T; Numata T; Oda A; Kanno M; Tanaka M; Eiro M; Satoh M; Kazama JJ CEN Case Rep; 2019 Nov; 8(4):239-245. PubMed ID: 31077056 [TBL] [Abstract][Full Text] [Related]
7. Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with Bilateral Adrenal Hemorrhage in Two Caucasian Patients. Ducoux G; Guerber A; Durel CA; Asli B; Fadlallah J; Hot A Am J Case Rep; 2020 Apr; 21():e919536. PubMed ID: 32249274 [TBL] [Abstract][Full Text] [Related]
8. TAFRO Syndrome with Renal Thrombotic Microangiopathy: Insights into the Molecular Mechanism and Treatment Opportunities. Tu KH; Fan PY; Chen TD; Chuang WY; Wu CY; Ku CL; Tian YC; Yang CW; Fang JT; Yang HY Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208103 [TBL] [Abstract][Full Text] [Related]
9. TAFRO syndrome with refractory thrombocytopenia responding to tocilizumab and romiplostim: a case report. Noda-Narita S; Sumida K; Sekine A; Hoshino J; Mise K; Suwabe T; Hayami N; Yamanouchi M; Ueno T; Mizuno H; Kawada M; Hiramatsu R; Hasegawa E; Sawa N; Takaichi K; Ohashi K; Fujii T; Ubara Y CEN Case Rep; 2018 May; 7(1):162-168. PubMed ID: 29468524 [TBL] [Abstract][Full Text] [Related]
11. Thrombotic microangiopathy on kidney biopsy in a patient with TAFRO syndrome. Ozeki T; Tsuji M; Yamamoto J; Shigematsu C; Maruyama S CEN Case Rep; 2018 Nov; 7(2):243-247. PubMed ID: 29766467 [TBL] [Abstract][Full Text] [Related]
12. A severe case of thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly syndrome with myocardial and skeletal muscle calcification despite hypocalcemia: a case report. Minomo S; Fujiwara Y; Sakashita S; Takamura A; Nagata K J Med Case Rep; 2021 Jan; 15(1):3. PubMed ID: 33402219 [TBL] [Abstract][Full Text] [Related]
13. An extranodal histopathological analysis of idiopathic multicentric Castleman disease with and without TAFRO syndrome. Kurose N; Mizutani KI; Kumagai M; Shioya A; Guo X; Nakada S; Fujimoto S; Kawabata H; Masaki Y; Takai K; Aoki S; Kojima M; Nakamura S; Kida M; Yamada S Pathol Res Pract; 2019 Mar; 215(3):410-413. PubMed ID: 30642741 [TBL] [Abstract][Full Text] [Related]
14. Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease. Nishimura Y; Fajgenbaum DC; Pierson SK; Iwaki N; Nishikori A; Kawano M; Nakamura N; Izutsu K; Takeuchi K; Nishimura MF; Maeda Y; Otsuka F; Yoshizaki K; Oksenhendler E; van Rhee F; Sato Y Am J Hematol; 2021 Oct; 96(10):1241-1252. PubMed ID: 34265103 [TBL] [Abstract][Full Text] [Related]
15. An autopsy case of TAFRO syndrome with membranoproliferative glomerulonephritis-like lesions. Hashimoto K; Sano T; Honma Y; Ida M; Tominaga H; Sawada A; Abe T; Takahashi H; Shimada Y; Masaki T; Kamata M; Naito S; Aoyama T; Takeuchi Y; Akiya M; Inukai M; Nakata N CEN Case Rep; 2019 Feb; 8(1):48-54. PubMed ID: 30244358 [TBL] [Abstract][Full Text] [Related]
16. Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody. Kawabata H; Kotani S; Matsumura Y; Kondo T; Katsurada T; Haga H; Kadowaki N; Takaori-Kondo A Intern Med; 2013; 52(13):1503-7. PubMed ID: 23812199 [TBL] [Abstract][Full Text] [Related]
17. Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids. Fujiwara S; Mochinaga H; Nakata H; Ohshima K; Matsumoto M; Uchiba M; Mikami Y; Hata H; Okuno Y; Mitsuya H; Nosaka K Int J Hematol; 2016 Jun; 103(6):718-23. PubMed ID: 26980221 [TBL] [Abstract][Full Text] [Related]
18. Acute Kidney Injury Caused by TAFRO Syndrome in a Chinese Patient: Efficacy of Long-Term Corticosteroids Combined with Bortezomib and Cyclophosphamide. Xia P; Zhang L; Zou M; Zhang T; Li R; Shi X; Wang J; Qin Y; Li X; Li J; Chen L Kidney Blood Press Res; 2020; 45(4):623-630. PubMed ID: 32492687 [TBL] [Abstract][Full Text] [Related]
19. Successful treatment with tacrolimus in TAFRO syndrome: two case reports and literature review. Shirai T; Onishi A; Waki D; Saegusa J; Morinobu A Medicine (Baltimore); 2018 Jun; 97(23):e11045. PubMed ID: 29879072 [TBL] [Abstract][Full Text] [Related]
20. Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012). Kawabata H; Takai K; Kojima M; Nakamura N; Aoki S; Nakamura S; Kinoshita T; Masaki Y J Clin Exp Hematop; 2013; 53(1):57-61. PubMed ID: 23801135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]